Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast

Virchows Archiv

Volumn 448, Issue 4, 2006, Pages 500-505

  Kuroda, Hajime ^a   Tamaru, Jun Ichi ^a   Takeuchi, Ikuya ^a   Ohnisi, Kiyoshi ^a   Sakamoto, Goi ^b   Adachi, Akiko ^c   Kaneko, Kou ^c   Itoyama, Shinji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c SAITAMA RED CROSS HOSPITAL   (Japan)

Author keywords

catenin; catenin; Breast cancer; E cadherin; Tubulolobular carcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; TUBULOLOBULAR CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ALPHA CATENIN; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645567919     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0096-y     Document Type: Article

References (29)

1. Berg J, Hutter R (1995) Breast cancer. Cancer 75:257-269
2. Boller K, Vestweber D, Kemler R (1985) Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol 100:327-332
3. Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Bocker W (2000) Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 53:118-121
4. Bukholm IK, Nesland JM, Karesen R, Jacobsen U, Borresen-Dale AL (1998) E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 433:223-228
5. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183:404-411
6. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
7. Fisher ER, Gregorio RM, Redmond C, Fisher B (1977) Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol 8:679-683
8. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142:987-993
9. Green I, McCormick B, Cranor M, Rosen PP (1997) A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 21:653-657
10. Gumbiner B (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
11. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M, Kemler R (1991) The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc Natl Acad Sci U S A 88:9156-9160
12. Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061-2069
13. Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS, Pignatelli M (2001) Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur J Surg Oncol 27:31-36
14. McCrea PD, Turck CW, Gumbiner B (1991) A homolog of the armadillo protein in Drosophilia (plakoglobin) associated with E-cadherin. Science 254:1359-1361
15. Moll R, Mitze M, Frixen U, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731-1742
16. Nagafuchi A, Takeichi M (1988) Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 7:3679-3684
17. Nagafuchi A, Takeichi M (1989) Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell 1:37-44
18. Nagafuchi A, Takeuchi M, Tsukita S (1991) The 102 kD cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell 65:849-857
19. Nelson W (1994) Regulation of cell adhesion and development of epithelial cell surface polarity. Curr Top Membr 41:123-142
20. Ozawa M, Kelmer R (1992) Molecular organization of the uvomorulin-catenin complex. J Cell Biol 116:989-996
21. Ozawa M, Baribault H, Kemler R (1989) The cytoplasmic domain of the cell adhesion molecule ??unvomorulin associates with three independent proteins structurally related in different species. EMBO J 8:1711-1717
22. Rasbridge S, Gillett C, Sampson S, Walsh F, Millis R (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169:245-250
23. Rimm D, Sinard J, Morrow J (1995) Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest 72:506-512
24. Rosen PP (1999) Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 23:1561
25. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455
26. Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627
27. Vestweber D, Kemler R (1984) Some structural and functional aspects of the cell adhesion molecule uvomorulin. Cell differ 15:269-273
28. Wheeler DT, Tai LH, Bratthauer GL, Waldner DL, Tavassoli FA (2004) Tubulolobular carcinoma of the breast. An analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. Am J Surg Pathol 28:1587-1593
29. Zschiesche W, Schonborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, Birchmeier W (1997) Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 17:561-567